Dr. Tetsuya Tanaka
Ricoh Biosciences, Inc., Baltimore, Maryland, USA
“Our main purpose of using MaxTwo is to assess the quality and maturation of the human iPSC-derived neurons we produce using our Quick-TissueTM technology. Unlike other commercially available MEA systems, MaxTwo has an outstanding capability to measure and track action potentials in single neurons due to how the electrodes are arrayed in such a high density manner."